Sumandeep Vidyapeeth Vadodara B.Pharma {Lateral} : Fees 2026, Course Duration, Dates, Eligibility
Sumandeep Vidyapeeth Vadodara B.Pharma {Lateral} is offered as 3 Years Full Time program. The minimum eligibility criteria for B.Pharma {Lateral} is D.PHARMA. The total fees for Sumandeep Vidyapeeth Vadodara B.Pharma {Lateral} in 2025 is ₹ 3.7 Lakhs for the complete course duration, which includes total tuition fees of ₹ 3.6 Lakhs. Earlier, the fees in 2022 - 2023 for B.Pharma {Lateral} was ₹ 3 Lakhs.
Sumandeep Vidyapeeth Vadodara B.Pharma {Lateral} fees in first year is ₹ 1.3 Lakhs. The detailed fees is mentioned below.
- The first year tuition fees is ₹ 1.2 Lakhs.
- The Caution Fee is ₹ 10,000.
Sumandeep Vidyapeeth Vadodara Hostel Fee for Male is ₹ 25,000 to 1.6 Lakhs. Hostel Fee for Female at Sumandeep Vidyapeeth Vadodara is ₹ 25,000 to 1.25 Lakhs.
Check Sumandeep Vidyapeeth Vadodara Admission 2025
Sumandeep Vidyapeeth Vadodara B.Pharma {Lateral} Fees 2025
| Fees (2025 - 2026) | Year 1 (in INR) | Year 2 (in INR) | Year 3 (in INR) |
|---|---|---|---|
| Tuition Fees | ₹120000 | ₹120000 | ₹120000 |
| Caution Fee | ₹10000 | - | - |
| Yearly Fees | ₹130000 | ₹120000 | ₹120000 |
* Fees is refundable
Sumandeep Vidyapeeth Vadodara B.Pharma {Lateral} Previous Fees
| Fees | Year 1 (in INR) | Year 2 (in INR) | Year 3 (in INR) |
|---|---|---|---|
| Tuition Fees | ₹100000 | ₹100000 | ₹100000 |
| Yearly Fees | ₹100000 | ₹100000 | ₹100000 |
* Fees is refundable
Sumandeep Vidyapeeth Vadodara B.Pharma {Lateral} Admission 2025
The minimum eligibility for admission to B.Pharma {Lateral} at Sumandeep Vidyapeeth Vadodara is D.PHARMA.
Also Check:
| Course Highlights | Details |
|---|---|
| duration | 3 Years (Full Time) |
| course level | UG (Degree) |
| mode of study | On Campus |
| total fees | ₹ 3.1 Lakhs |
| eligibility | D.PHARMA |
Table of Contents
Sumandeep Vidyapeeth Vadodara B.Pharma {Lateral} Fees
| Fee Type | Total Amount (INR) |
|---|---|
| total academic fee | ₹3.1 Lakhs |
| hostel fee | ₹75,000 |
| total fee | ₹3.85 Lakhs |
SUBSCRIBE TO OUR NEWS LETTER
Comments